|
by Klemp, Marianne, Neilson, Aileen Rae, Freiesleben de Blasio, Birgitte
Published 2007
“..., discount rate, and time horizon of the analysis. Conclusion Under several plausible assumptions, our...”Published 2007
Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH)
|
by Movik, Espen, Hamidi, Vida, Aaserud, Morten, Neilson, Aileen Rae
Published 2008
“... The evidence base regarding the cost-effectiveness of cetuximab is, at the time of writing, weak, particularly...”Published 2008
Norwegian Knowledge Centre for the Health Services
|
by Steiro, Asbjørn, Smedslund, Geir, Hammerstrøm, Karianne Thune
Published 2007
“... dependence and amount of time spent with non-smokers are important factors for duration of smoking cessation...”Published 2007
Knowledge Centre for the Health Services at the Norwegian Institute of Public Health (NIPH)
|
by Jiménez, Enrique, Wisløff, Torbjørn, Klemp, Marianne
Published 2014
“... approximately NOK 780/dose.3. From a societal perspective, i.e. when costs to patients for time used under...”Published 2014
Norwegian Knowledge Centre for the Health Services
|
by Movik, Espen, Hamidi, Vida, Natvig Norderhaug, Inger, Klemp, Marianne
Published 2009
“..., with Norwegian cost data associated with the treatment alternatives. Results Mean progression-free time...”Published 2009
Norwegian Knowledge Centre for the Health Services
|
by Blaasvær, Nora, Nøkleby, Heid, Johansen, Sissel, Berg, Rigmor C.
Published 2015
Published 2015
Norwegian Knowledge Centre for the Health Services
|
by Wisløff, Torbjørn, Hamidi, Vida, Ringerike, Tove, Harboe, Ingrid
Published 2010
Published 2010
Norwegian Knowledge Centre for the Health Services